Cargando…
Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1
BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder with a prevalence of 1:3000 births and a wide variety of clinical manifestations. Cutaneous neurofibromas (cNF) are among the most common visible manifestations of NF1 and present a major clinical burden for patient...
Autores principales: | Oliveira, Lisa Brauer, Geller, Mauro, Cunha, Karin Soares, Santos, Alessandra, Bernacchi, Allan, Rubenstein, Allan E., Takirambudde, Sanyu, Mezitis, Spyros, de Almeida Ito Brum, Carolina, Darrigo, Luiz Guilherme, Ribeiro, Marcia Gonçalves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010391/ https://www.ncbi.nlm.nih.gov/pubmed/33817379 http://dx.doi.org/10.1016/j.heliyon.2021.e06518 |
Ejemplares similares
-
Determination of Vitamin D Levels in Patients With Neurofibromatosis
Type 1 in the Pediatric Age Group
por: Santos, Alessandra, et al.
Publicado: (2020) -
Plexiform neurofibroma in the ear canal of a patient with Type I Neurofibromatosis
por: Geller, Mauro, et al.
Publicado: (2015) -
Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1
por: Rozza-de-Menezes, Rafaela E., et al.
Publicado: (2017) -
Progesterone and Estrogen Receptors in Neurofibromas of Patients with NF1
por: Geller, Mauro, et al.
Publicado: (2008) -
Treatment of Cutaneous Neurofibromas in Patients with Neurofibromatosis Type 1
por: Wozniak, Bartosz, et al.
Publicado: (2023)